Profile: Retinapharma Technologies, Inc. is a development stage biotechnology company. We focus on the prevention, diagnosis & treatment of neurologically based conditions of the retina, brain, spinal cord and peripheral nerves. We also specialise in drug development of deprenyl-based propargylamines and drug delivery carriers. Our phototarget station is an integrated digital fundus camera capable of real-time viewing of the retina and contains the source of specific wavelengths of light necessary for light-targeted delivery (LTD) of drugs.